Detailed Information on Publication Record
2015
Úspěšnost léčebných modalit nádoru orofaryngu ve vztahu k HPV etiologii
BINKOVÁ, Hana, Zuzana HORÁKOVÁ, Rom KOSTŘICA, Karel VESELÝ, J. KLOZAR et. al.Basic information
Original name
Úspěšnost léčebných modalit nádoru orofaryngu ve vztahu k HPV etiologii
Name (in English)
Success rate of oropharyngeal cancer treatment modalities in relation to HPV etiology
Authors
BINKOVÁ, Hana (203 Czech Republic, guarantor), Zuzana HORÁKOVÁ (203 Czech Republic, belonging to the institution), Rom KOSTŘICA (203 Czech Republic, belonging to the institution), Karel VESELÝ (203 Czech Republic, belonging to the institution), J. KLOZAR (203 Czech Republic), E. KOŠLABOVÁ (203 Czech Republic), E. LUKEŠOVÁ (203 Czech Republic), M. GREGA (203 Czech Republic), E. HAMŠÍKOVÁ (203 Czech Republic) and R. TACHEZY (203 Czech Republic)
Edition
XXXIX. brněnské onkologické dny a XXIX. konference pro nelékařské zdravotnické pracovníky, 2015
Other information
Language
Czech
Type of outcome
Konferenční abstrakt
Field of Study
30200 3.2 Clinical medicine
Country of publisher
Czech Republic
Confidentiality degree
není předmětem státního či obchodního tajemství
RIV identification code
RIV/00216224:14110/15:00084671
Organization unit
Faculty of Medicine
ISSN
Keywords in English
oropharyngeal cancer; HPV; prognosis; surgical and nonsurgical treatment
Tags
Změněno: 13/11/2015 08:46, Ing. Mgr. Věra Pospíšilíková
V originále
In the study the success of surgical and nonsurgical treatment in patients with advanced oropharyngeal cancer (OPC) was compared. Patients with HPV-associated tumors have a significantly better prognosis regardless of the type of treatment. The prognostic benefit of HPV positivity is probably not linked to the treatment modality. Although therapy protocols do not take HPV status into account yet, routine HPV testing of all OPC samples before therapy is highly desirable.
In English
In the study the success of surgical and nonsurgical treatment in patients with advanced oropharyngeal cancer (OPC) was compared. Patients with HPV-associated tumors have a significantly better prognosis regardless of the type of treatment. The prognostic benefit of HPV positivity is probably not linked to the treatment modality. Although therapy protocols do not take HPV status into account yet, routine HPV testing of all OPC samples before therapy is highly desirable.